Clinical Trials Directory

Trials / Unknown

UnknownNCT05841082

Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry

Coronary RevascUlarIzation in Patients With End-StagE Renal Disease on Dialysis in China-Retrospective Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
1,249 (actual)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Coronary artery disease (CAD) is the leading cause of death in end-stage renal disease (ESRD) patients requiring dialysis. There are limited data on clinical characteristics, treatment strategies and outcomes in this special patient population in China. As a nationwide, observational, multicenter cohort study, this study consecutively included ESRD patients on dialysis with significant CAD at 30 tertiary care centers in 12 provinces in China from January 2015 to June 2021. Patient data collected included demographics, comorbidities, cardiac history, cardiac function, location and severity of CAD, procedural information, medications, and clinical events.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2021-06-30
Completion
2024-06-30
First posted
2023-05-03
Last updated
2023-05-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05841082. Inclusion in this directory is not an endorsement.

Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry (NCT05841082) · Clinical Trials Directory